C1INH Inhibitor Preoperative and Post Kidney Transplant to Prevent DGF & IRI

NCT02134314 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

70

Enrollment

OTHER

Sponsor class

Conditions

End Stage Renal Disease
Kidney Failure
Delayed Graft Function
Ischemic Reperfusion Injury

Interventions

DRUG: C1 Esterase Inhibitor
DRUG: Placebo

Sponsor

Cedars-Sinai Medical Center